Protocol No
ALLIANCE-A032103-MODERN
Staff Member
Ariel Nelson
Phase
II/III
Summary
The purpose of this study is to determine whether a blood test can help us make better decisions about who should get immunotherapy after surgery to remove the bladder for bladder cancer and which immunotherapy treatment is best.
Objective
Testing the role of DNA released from tumor cells into the blood in guiding the use of immunotherapy after surgical removal of the bladder for bladder cancer treatment.
Study Sites
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov